Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,0.78 [0.66-0.93],0.0057689858211667
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,1.06 [1.02-1.11],0.0060169616905594
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.84 [0.74-0.96],0.0095172853008978
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.61 [0.46-0.80],0.0005088494625962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,1.32 [1.08-1.62],0.0080630766129985
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,1.33 [1.08-1.63],0.0074296819056391
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,0.73 [0.58-0.92],0.0078454173268129
